High Performance Network - Tiered HPN
Blue Card PPO
Blue Card High Performance Network HPN
Dr. Aidan Porter, MD
Pediatric Nephrology*
Age 40
Be the first to review this provider!
Dr. Aidan Porter, MD
Be the first to review this provider!
Pittsburgh, PA
Accepting new patients
Clinical Overview
Dr. Aidan Porter, MD works in Pittsburgh, PA as
Insurance & Payment Information
* Please verify this information when scheduling an appointment.
-
-
APCN Open Access Aetna SelectOpen Choice PPOPremier Care Network Plus - Innovation HealthChoice Plus POS IIAetnaSelectPremier Care Network APCN Choice (OAMC) POS IIElect Choice (Open Access) EPOManaged Choice (Open Access) POS
-
Curative PPOCurative EPOCurative PPO Plus
-
Personal Choice PPO
-
BCBS PPOPerformance BlueKeystoneBluePPOBlue PPOBlue High Performance NetworkmyBlue Access EPOCommunity Blue PPO
-
First Health (Coventry Health Care) PPO
-
Wellspan Health PPOCapital Blue Cross PPO
-
Navigate POSChoice Plus POSNexus Open AccessOptions PPONavigate HMOMedica ChoiceMD IPA/Optimum Choice HMO/Preferred POS HMO-POS
-
MVP Health Plan EPO
-
Choice POSChoice Care Network PPOChoice Care PPO
-
BluePreferred PPO
-
Parnter Network Plans HMOPremium Network Plans - PPO and EPO PlansPremium Network Plans PPO
Office Locations
-
UPMC Children's Hospital of Pittsburgh4401 Penn Ave, Pittsburgh, PA 15224
Patient Experience & Satisfaction
Be the first to leave a review
How likely are you to recommend Dr. Porter?
Step 1 of 3
Your review of Dr. Aidan Porter, MD
50 characters remaining
1000 characters remaining
Was this a Telehealth appointment?
(This will display with your review)
Your email is used to confirm your review and will NOT appear in the review.
This name will appear with your review. If left blank, we'll use "Anonymous".
RVO Health property, Medical News Today, is owned by RVO Health. Please review our terms of use for more.
Help other patients find the right care by sharing a few more details about your visit.
Last step! Confirm your email.
We've sent an email to
Once you confirm, you can close this window.
Thank you for your review!
Your review has been confirmed and will be published after verification.
Thank you for your review!
We've sent a confirmation email. Your review will appear after you confirm it.
Please allow up to 30 seconds for the email to arrive. Don't see it? Make sure to check your 'spam' and 'updates' folder. Once you've confirmed your review, you can close this window.
Medical Expertise & Background
Specialties*
Pediatrics
Pediatric Nephrology
- *Medical News Today does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.
Common Patient Questions
Dr. Aidan Porter, MD accepts new patients on Medical News Today.
Dr. Porter accepts Blue Cross Blue Shield, Aetna, Curative, Amerihealth, Highmark Blue Cross Blue Shield, First Health, Capital Blue Cross, UnitedHealthCare, MVP Health Care, Humana, CareFirst BlueCross BlueShield and UPMC Health Plan as well as many others. See all of the insurances Dr. Porter accepts here.
Dr. Porter's office is located at 4401 Penn Ave Pittsburgh, PA 15224. Get a map and directions to Dr. Porter's office here.
Dr. Porter does not have any reviews yet.
Dr. Porter is board certified in
Education & Credentials
Board Certifications
- Pediatric Nephrology and Pediatrics
Claim Your Profile
Are you Dr. Aidan Porter, MD?
Affiliated Hospitals & Medical Centers
Know Before You Go
Preventive care: what doctors want you to know
Preventive care can help identify current or future health and medical concerns before they become major.
Featured Stories
The FDA has approved Moderna's new mRNA flu vaccine for adults ages 50 years and older. Moderna expects the vaccine to be available in the United States for the 2026 to 2027 flu season.
A natural compound derived from plant foods containing a certain type of polyphenol may help improve heart function in people with heart failure, a study in animals and human tissue models has found.
Moderna and Merck's neoantigen treatment, combining a personalized mRNA cancer vaccine with the immunotherapy drug pembrolizumab significantly reduced the risk of melanoma recurrence in a phase 3 trial.
Explore More Providers
- Pediatric Nephrologists for Acute Kidney Failure
- Pediatric Nephrologists for Autosomal Dominant Polycystic Kidney Disease (ADPKD)
- Pediatric Nephrologists for Calcium Metabolism Disorders
- Pediatric Nephrologists for Chronic Kidney Disease Stage II
- Pediatric Nephrologists for Chronic Kidney Diseases
- Pediatric Nephrologists for Congenital Anomalies of Kidney
- Pediatric Nephrologists for Congenital Cystic Kidney Disease
- Pediatric Nephrologists for Congenital Medullary Cystic Kidney Disease
- Pediatric Nephrologists for Congenital Renal Agenesis and Dysgenesis
- Pediatric Nephrologists for Congenital Renal Dysplasia
- Pediatric Nephrologists for Dehydration
- Pediatric Nephrologists for End-Stage Renal Disease
